RCUS
Arcus Biosciences, Inc. · Healthcare
CFO II Robert C. Goeltz sold $81K of Arcus Biosciences, Inc.
Sold$81,142
$20.04Price
4,049Shares
−6%Stake
What RCUS did after the filing
- The stock from Fri, Jun 9 close, $21.10
- −8.6%
- S&P 500, same days
- +6.3%
Measured over 30 trading days, to the Jul 25 close.
Traded Wed, Jun 7. Filed Fri, Jun 9, 12:05 PM ET, during the session. Returns use the Jun 9 close and the Jul 25 close. Not investment advice.